<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:6080f978-0d72-4eb3-93e5-cdded13291a4,g:8e18d492-f980-45f6-9711-81c6722a7281-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="jazz-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2c7001c1-b028-452c-bcc9-b0144e52d141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4b2e65a4-3e72-4a0d-81b2-041c82e0dd3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2c7001c1-b028-452c-bcc9-b0144e52d141" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4b2e65a4-3e72-4a0d-81b2-041c82e0dd3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_e449825c-d3a0-487f-9db7-84dada9c5de7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2c7001c1-b028-452c-bcc9-b0144e52d141" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_e449825c-d3a0-487f-9db7-84dada9c5de7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_f24d0c74-cd3a-4739-883b-24de54a2b9e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2c7001c1-b028-452c-bcc9-b0144e52d141" xlink:to="loc_us-gaap_InventoryNet_f24d0c74-cd3a-4739-883b-24de54a2b9e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_7ffd1f17-38f3-43c2-97bb-bb13eaa874cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2c7001c1-b028-452c-bcc9-b0144e52d141" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_7ffd1f17-38f3-43c2-97bb-bb13eaa874cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_d1b1f729-0641-4297-af5c-3edb9b1e3f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2c7001c1-b028-452c-bcc9-b0144e52d141" xlink:to="loc_us-gaap_OtherAssetsCurrent_d1b1f729-0641-4297-af5c-3edb9b1e3f9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6303eca7-b6ea-4e74-9a6f-b2b9ab5a4bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_21684a03-322a-48a3-9aee-1681e0ecfca8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6303eca7-b6ea-4e74-9a6f-b2b9ab5a4bcc" xlink:to="loc_us-gaap_CommonStockValue_21684a03-322a-48a3-9aee-1681e0ecfca8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_NonvotingEuroDeferredShares_e1ece76c-62f3-4251-a471-a77a63e6e0fa" xlink:href="jazz-20230331.xsd#jazz_NonvotingEuroDeferredShares"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6303eca7-b6ea-4e74-9a6f-b2b9ab5a4bcc" xlink:to="loc_jazz_NonvotingEuroDeferredShares_e1ece76c-62f3-4251-a471-a77a63e6e0fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CapitalRedemptionReserve_4748a3bc-d483-496f-97aa-4b0dec3db451" xlink:href="jazz-20230331.xsd#jazz_CapitalRedemptionReserve"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6303eca7-b6ea-4e74-9a6f-b2b9ab5a4bcc" xlink:to="loc_jazz_CapitalRedemptionReserve_4748a3bc-d483-496f-97aa-4b0dec3db451" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1729f1d9-73f7-47fa-b294-a2e5f9dd492c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6303eca7-b6ea-4e74-9a6f-b2b9ab5a4bcc" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1729f1d9-73f7-47fa-b294-a2e5f9dd492c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_054d7feb-76df-4a1c-bb23-e496db1a72fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6303eca7-b6ea-4e74-9a6f-b2b9ab5a4bcc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_054d7feb-76df-4a1c-bb23-e496db1a72fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d64216f6-4923-4ef9-9b31-64464bd340d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6303eca7-b6ea-4e74-9a6f-b2b9ab5a4bcc" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d64216f6-4923-4ef9-9b31-64464bd340d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b4e4f3fb-50e0-4835-9570-d693d276746e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_a5adabe7-9690-45ea-a815-d19b6b193c72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b4e4f3fb-50e0-4835-9570-d693d276746e" xlink:to="loc_us-gaap_AccountsPayableCurrent_a5adabe7-9690-45ea-a815-d19b6b193c72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_fb35ab53-0526-463d-a494-a810af783679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b4e4f3fb-50e0-4835-9570-d693d276746e" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_fb35ab53-0526-463d-a494-a810af783679" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_eb4e6680-2f70-4dbf-86f8-7359495e60d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b4e4f3fb-50e0-4835-9570-d693d276746e" xlink:to="loc_us-gaap_LongTermDebtCurrent_eb4e6680-2f70-4dbf-86f8-7359495e60d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_875e3ec4-633f-48c9-b08b-8811e1de4842" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b4e4f3fb-50e0-4835-9570-d693d276746e" xlink:to="loc_us-gaap_TaxesPayableCurrent_875e3ec4-633f-48c9-b08b-8811e1de4842" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ed5b69e5-dd63-436e-ac6c-2e478e3c7427" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b4e4f3fb-50e0-4835-9570-d693d276746e" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ed5b69e5-dd63-436e-ac6c-2e478e3c7427" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_790c97d5-2b85-490a-9f17-4a2fa5f889a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_510bc010-2f58-4b96-a245-1bdbb9d1c78d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_790c97d5-2b85-490a-9f17-4a2fa5f889a1" xlink:to="loc_us-gaap_AssetsCurrent_510bc010-2f58-4b96-a245-1bdbb9d1c78d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1d5094a4-159c-4451-a264-0433455b1b69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_790c97d5-2b85-490a-9f17-4a2fa5f889a1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1d5094a4-159c-4451-a264-0433455b1b69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1511ef7e-34c0-4062-b14a-b377183d3af2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_790c97d5-2b85-490a-9f17-4a2fa5f889a1" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1511ef7e-34c0-4062-b14a-b377183d3af2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7bdaf70d-b8c1-43d3-a2bb-39e396a33b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_790c97d5-2b85-490a-9f17-4a2fa5f889a1" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7bdaf70d-b8c1-43d3-a2bb-39e396a33b3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ae56f94f-af89-428e-844c-0b8e88dc84f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_790c97d5-2b85-490a-9f17-4a2fa5f889a1" xlink:to="loc_us-gaap_Goodwill_ae56f94f-af89-428e-844c-0b8e88dc84f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_032242bf-5806-4e43-84c5-0c8832393702" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_790c97d5-2b85-490a-9f17-4a2fa5f889a1" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_032242bf-5806-4e43-84c5-0c8832393702" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_c69abc1d-c51e-46d6-ad6f-499a15991945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_790c97d5-2b85-490a-9f17-4a2fa5f889a1" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_c69abc1d-c51e-46d6-ad6f-499a15991945" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_39b9d332-6760-4e43-acae-aeb391319414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_790c97d5-2b85-490a-9f17-4a2fa5f889a1" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_39b9d332-6760-4e43-acae-aeb391319414" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ee1f392e-b76e-4f60-b46e-b7353f737e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2d5c7820-152f-44a0-8ec0-6707d2f723b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ee1f392e-b76e-4f60-b46e-b7353f737e19" xlink:to="loc_us-gaap_LiabilitiesCurrent_2d5c7820-152f-44a0-8ec0-6707d2f723b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_29f6c176-dc04-438b-8a2c-c700f2f421f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ee1f392e-b76e-4f60-b46e-b7353f737e19" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_29f6c176-dc04-438b-8a2c-c700f2f421f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_216f3c94-c826-4b0a-9c93-1dee695bdc4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ee1f392e-b76e-4f60-b46e-b7353f737e19" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_216f3c94-c826-4b0a-9c93-1dee695bdc4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e73d5a3d-7b90-42d6-bc35-2526db703dde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ee1f392e-b76e-4f60-b46e-b7353f737e19" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e73d5a3d-7b90-42d6-bc35-2526db703dde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_3e7e6c4c-7c06-47ac-bf97-8dc69ad4d1b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ee1f392e-b76e-4f60-b46e-b7353f737e19" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_3e7e6c4c-7c06-47ac-bf97-8dc69ad4d1b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_405cba99-e973-4df9-8fd7-e6c4dac68584" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ee1f392e-b76e-4f60-b46e-b7353f737e19" xlink:to="loc_us-gaap_CommitmentsAndContingencies_405cba99-e973-4df9-8fd7-e6c4dac68584" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d3752470-02e6-4635-b5c2-023d54f8cee8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ee1f392e-b76e-4f60-b46e-b7353f737e19" xlink:to="loc_us-gaap_StockholdersEquity_d3752470-02e6-4635-b5c2-023d54f8cee8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="jazz-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1815558c-109c-4a91-9d24-afebe50e654a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a3b27d5e-ccaa-410d-8dd3-6de0c3e65bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1815558c-109c-4a91-9d24-afebe50e654a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a3b27d5e-ccaa-410d-8dd3-6de0c3e65bc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6d4df5ea-e458-48c5-8cd7-7eb269872630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1815558c-109c-4a91-9d24-afebe50e654a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6d4df5ea-e458-48c5-8cd7-7eb269872630" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_661113cb-4586-4d42-8ca4-b1a162be579f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1815558c-109c-4a91-9d24-afebe50e654a" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_661113cb-4586-4d42-8ca4-b1a162be579f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5be0ae99-6d4f-48a6-8353-d7e1bd160dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_dd6dcb12-0f3d-4886-bf99-515f37a301ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5be0ae99-6d4f-48a6-8353-d7e1bd160dcc" xlink:to="loc_us-gaap_OperatingIncomeLoss_dd6dcb12-0f3d-4886-bf99-515f37a301ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_a1692b44-1bb3-4945-9293-8bdd6d1fd24c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5be0ae99-6d4f-48a6-8353-d7e1bd160dcc" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_a1692b44-1bb3-4945-9293-8bdd6d1fd24c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_844e0148-e31f-4383-9cbd-993ad88cdb41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5be0ae99-6d4f-48a6-8353-d7e1bd160dcc" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_844e0148-e31f-4383-9cbd-993ad88cdb41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9b79dfc2-86f2-4bf1-a2ec-b615567baa3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_61ff1a77-b1d7-4a31-9da1-534a69f89c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9b79dfc2-86f2-4bf1-a2ec-b615567baa3d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_61ff1a77-b1d7-4a31-9da1-534a69f89c5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_36d55634-f18d-4989-92fc-20b1d183429f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9b79dfc2-86f2-4bf1-a2ec-b615567baa3d" xlink:to="loc_us-gaap_CostsAndExpenses_36d55634-f18d-4989-92fc-20b1d183429f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_2e5791b8-15e5-47af-a256-90a7513e3907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_b61aa8c7-e041-47c4-b4a0-91294a970a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_2e5791b8-15e5-47af-a256-90a7513e3907" xlink:to="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_b61aa8c7-e041-47c4-b4a0-91294a970a5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_2acc96c0-2f74-43d7-9e1f-5ae2ccf1c6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_2e5791b8-15e5-47af-a256-90a7513e3907" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_2acc96c0-2f74-43d7-9e1f-5ae2ccf1c6e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment_25c43991-3d95-47bf-aa38-b2728c1ceb25" xlink:href="jazz-20230331.xsd#jazz_CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_2e5791b8-15e5-47af-a256-90a7513e3907" xlink:to="loc_jazz_CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment_25c43991-3d95-47bf-aa38-b2728c1ceb25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d7cc0d98-16c6-4333-92e9-8ff78443c029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_2e5791b8-15e5-47af-a256-90a7513e3907" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d7cc0d98-16c6-4333-92e9-8ff78443c029" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_a08e1862-a940-40ec-b617-81c31af1cecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_2e5791b8-15e5-47af-a256-90a7513e3907" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_a08e1862-a940-40ec-b617-81c31af1cecc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="jazz-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a7a8abc5-3383-4584-b416-62c396881909" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_OtherComprehensiveIncomeLossFairValueHedgeGainLossAfterReclassificationAndTax_a7a73591-0d64-459d-b915-f23d56019e60" xlink:href="jazz-20230331.xsd#jazz_OtherComprehensiveIncomeLossFairValueHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a7a8abc5-3383-4584-b416-62c396881909" xlink:to="loc_jazz_OtherComprehensiveIncomeLossFairValueHedgeGainLossAfterReclassificationAndTax_a7a73591-0d64-459d-b915-f23d56019e60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_bd12cfd2-6115-4660-8a01-d92507fe1cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a7a8abc5-3383-4584-b416-62c396881909" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_bd12cfd2-6115-4660-8a01-d92507fe1cfa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_d8911a4f-6817-4749-9ddc-dee4d79603f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2984ac99-6080-49e8-ab73-a80cd16ff9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_d8911a4f-6817-4749-9ddc-dee4d79603f1" xlink:to="loc_us-gaap_NetIncomeLoss_2984ac99-6080-49e8-ab73-a80cd16ff9c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_816762e7-16be-4d5b-82bc-501f1fc128f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_d8911a4f-6817-4749-9ddc-dee4d79603f1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_816762e7-16be-4d5b-82bc-501f1fc128f3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="jazz-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_25a4f222-f966-4012-acbc-67f693212456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_52e3e0ba-6f17-4534-bd71-f766bfc8f98c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_25a4f222-f966-4012-acbc-67f693212456" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_52e3e0ba-6f17-4534-bd71-f766bfc8f98c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_82343dfc-1beb-4fa2-ab10-d948ea289e50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_25a4f222-f966-4012-acbc-67f693212456" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_82343dfc-1beb-4fa2-ab10-d948ea289e50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_a8550b88-fbb4-431e-96cd-ac909179783f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_25a4f222-f966-4012-acbc-67f693212456" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_a8550b88-fbb4-431e-96cd-ac909179783f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bbbd05e9-22aa-4099-8ad7-b56158e583eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2490ad58-9f5c-403d-9530-3a2ee1b056a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bbbd05e9-22aa-4099-8ad7-b56158e583eb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2490ad58-9f5c-403d-9530-3a2ee1b056a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_41572661-a952-455f-a279-496b2c8292ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bbbd05e9-22aa-4099-8ad7-b56158e583eb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_41572661-a952-455f-a279-496b2c8292ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7aa6d45b-de49-4226-8f39-842f256b5a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bbbd05e9-22aa-4099-8ad7-b56158e583eb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7aa6d45b-de49-4226-8f39-842f256b5a4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d94f7301-a215-485f-a8ef-43cc9bf2a141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bbbd05e9-22aa-4099-8ad7-b56158e583eb" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d94f7301-a215-485f-a8ef-43cc9bf2a141" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57b65b78-21f3-4215-a364-f27ae079b305" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ProvisionForLossesOnAccountsReceivableAndInventory_8cf0a3b2-88d5-4aa1-80ff-71d7ee8f68f9" xlink:href="jazz-20230331.xsd#jazz_ProvisionForLossesOnAccountsReceivableAndInventory"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57b65b78-21f3-4215-a364-f27ae079b305" xlink:to="loc_jazz_ProvisionForLossesOnAccountsReceivableAndInventory_8cf0a3b2-88d5-4aa1-80ff-71d7ee8f68f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_c0c45bcf-60e5-4591-9e80-93f268555853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57b65b78-21f3-4215-a364-f27ae079b305" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_c0c45bcf-60e5-4591-9e80-93f268555853" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_8f554ef7-131c-43db-b210-7b765fe4a7af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57b65b78-21f3-4215-a364-f27ae079b305" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_8f554ef7-131c-43db-b210-7b765fe4a7af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_IncreaseDecreaseInOperatingLeaseAssets_36e8d668-fc57-49b2-80e7-a0d44ec8cf94" xlink:href="jazz-20230331.xsd#jazz_IncreaseDecreaseInOperatingLeaseAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57b65b78-21f3-4215-a364-f27ae079b305" xlink:to="loc_jazz_IncreaseDecreaseInOperatingLeaseAssets_36e8d668-fc57-49b2-80e7-a0d44ec8cf94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_499031cd-64f2-4aa4-870e-ccc391856f52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57b65b78-21f3-4215-a364-f27ae079b305" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_499031cd-64f2-4aa4-870e-ccc391856f52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9a69227d-cc7f-48cf-9032-73e7af0ebcb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57b65b78-21f3-4215-a364-f27ae079b305" xlink:to="loc_us-gaap_ShareBasedCompensation_9a69227d-cc7f-48cf-9032-73e7af0ebcb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f9ccef1c-c2ef-4fc1-bfea-5ba532f065a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57b65b78-21f3-4215-a364-f27ae079b305" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f9ccef1c-c2ef-4fc1-bfea-5ba532f065a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_22e8c684-c52d-4c6b-88f3-2c50fba91b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57b65b78-21f3-4215-a364-f27ae079b305" xlink:to="loc_us-gaap_Depreciation_22e8c684-c52d-4c6b-88f3-2c50fba91b6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent_42cb20ec-d1ef-45ca-b302-dc6809dade93" xlink:href="jazz-20230331.xsd#jazz_IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57b65b78-21f3-4215-a364-f27ae079b305" xlink:to="loc_jazz_IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent_42cb20ec-d1ef-45ca-b302-dc6809dade93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_910f89fa-b74f-4566-9992-d8e78f51be44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57b65b78-21f3-4215-a364-f27ae079b305" xlink:to="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_910f89fa-b74f-4566-9992-d8e78f51be44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_f70a5618-c6f3-470b-825b-a4feec6954d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57b65b78-21f3-4215-a364-f27ae079b305" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_f70a5618-c6f3-470b-825b-a4feec6954d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_InventoryStepUpValueAdjustment_fba119c1-441e-4e0c-838f-53545c731cdb" xlink:href="jazz-20230331.xsd#jazz_InventoryStepUpValueAdjustment"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57b65b78-21f3-4215-a364-f27ae079b305" xlink:to="loc_jazz_InventoryStepUpValueAdjustment_fba119c1-441e-4e0c-838f-53545c731cdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_NoncashInterestExpense_df52cbaa-58bd-4b0d-affb-2fa7c1b2d4df" xlink:href="jazz-20230331.xsd#jazz_NoncashInterestExpense"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57b65b78-21f3-4215-a364-f27ae079b305" xlink:to="loc_jazz_NoncashInterestExpense_df52cbaa-58bd-4b0d-affb-2fa7c1b2d4df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_c739a891-aa42-4465-b1b7-df77f215ebc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57b65b78-21f3-4215-a364-f27ae079b305" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_c739a891-aa42-4465-b1b7-df77f215ebc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_edd2ad0b-e92e-4eba-b346-99016061a4ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57b65b78-21f3-4215-a364-f27ae079b305" xlink:to="loc_us-gaap_NetIncomeLoss_edd2ad0b-e92e-4eba-b346-99016061a4ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_1b80841e-d537-41ce-864b-036bddb84b57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57b65b78-21f3-4215-a364-f27ae079b305" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_1b80841e-d537-41ce-864b-036bddb84b57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_0c46f6e5-4932-4836-9daf-75ae4a4148fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57b65b78-21f3-4215-a364-f27ae079b305" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_0c46f6e5-4932-4836-9daf-75ae4a4148fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c492d145-e099-438a-9c59-276fe5ae10e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57b65b78-21f3-4215-a364-f27ae079b305" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c492d145-e099-438a-9c59-276fe5ae10e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_0d97ec05-fff2-447a-960e-c2494df220b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="19" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57b65b78-21f3-4215-a364-f27ae079b305" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_0d97ec05-fff2-447a-960e-c2494df220b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d205b46d-a8a9-42ef-8f99-8b5f52d2dbcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="20" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57b65b78-21f3-4215-a364-f27ae079b305" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d205b46d-a8a9-42ef-8f99-8b5f52d2dbcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b1fa7ceb-767e-4968-afc1-4dd411b29ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="21" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57b65b78-21f3-4215-a364-f27ae079b305" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b1fa7ceb-767e-4968-afc1-4dd411b29ae1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e63e72c4-6346-4ffc-9602-b8e38279f219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_74b33872-3060-47fd-9cdd-a17e6aa14ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e63e72c4-6346-4ffc-9602-b8e38279f219" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_74b33872-3060-47fd-9cdd-a17e6aa14ec2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_fd054175-708d-41c8-bb87-4432c4717b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e63e72c4-6346-4ffc-9602-b8e38279f219" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_fd054175-708d-41c8-bb87-4432c4717b7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination_00b9a69c-38f5-4629-a4e8-448a6144a860" xlink:href="jazz-20230331.xsd#jazz_PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e63e72c4-6346-4ffc-9602-b8e38279f219" xlink:to="loc_jazz_PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination_00b9a69c-38f5-4629-a4e8-448a6144a860" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CashandAvailableforSaleSecuritiesSummaryofCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="jazz-20230331.xsd#CashandAvailableforSaleSecuritiesSummaryofCashandCashEquivalentsDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CashandAvailableforSaleSecuritiesSummaryofCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e02b8497-94cc-499d-b812-36ff8c2c8f37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0adeec16-4985-411d-9bf9-cea01e00bf41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e02b8497-94cc-499d-b812-36ff8c2c8f37" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0adeec16-4985-411d-9bf9-cea01e00bf41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8a14f75f-488e-4f90-8e64-7101b16b88f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e02b8497-94cc-499d-b812-36ff8c2c8f37" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8a14f75f-488e-4f90-8e64-7101b16b88f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_21ab542b-176e-4a5f-a3bd-272ea20948b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e02b8497-94cc-499d-b812-36ff8c2c8f37" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_21ab542b-176e-4a5f-a3bd-272ea20948b1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="jazz-20230331.xsd#FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_49b7ae03-eb06-4c55-a3ed-e8c6d694b1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0eed8375-1039-4941-b1ed-62b538243798" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_49b7ae03-eb06-4c55-a3ed-e8c6d694b1d1" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0eed8375-1039-4941-b1ed-62b538243798" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_5c239ce4-d2f9-4614-a6a8-770477059730" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_49b7ae03-eb06-4c55-a3ed-e8c6d694b1d1" xlink:to="loc_us-gaap_DerivativeAssets_5c239ce4-d2f9-4614-a6a8-770477059730" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_ccd0453d-4096-43d3-83fb-287acb0b26cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_683035c7-8ca6-4349-9489-7b4f5a61c05e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_ccd0453d-4096-43d3-83fb-287acb0b26cf" xlink:to="loc_us-gaap_DerivativeLiabilities_683035c7-8ca6-4349-9489-7b4f5a61c05e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesOffsettingAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="jazz-20230331.xsd#DerivativeInstrumentsandHedgingActivitiesOffsettingAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesOffsettingAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_3be8a1af-ee0f-420a-b86b-1fda75611429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_85bdb1bc-af82-46d1-821a-98ef0291e78a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeLiabilities_3be8a1af-ee0f-420a-b86b-1fda75611429" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_85bdb1bc-af82-46d1-821a-98ef0291e78a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_41e51005-27bf-442b-a3cc-d446c343c0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeLiabilities_3be8a1af-ee0f-420a-b86b-1fda75611429" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_41e51005-27bf-442b-a3cc-d446c343c0a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_1c57d1d5-10dd-4e51-85a7-5568a86d1a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_6e09c4aa-e46f-4e93-914a-9b1210a1502e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssets_1c57d1d5-10dd-4e51-85a7-5568a86d1a7f" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_6e09c4aa-e46f-4e93-914a-9b1210a1502e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossLiability_1749c543-6aea-4931-879e-3addeeb5d48a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetFairValueGrossLiability"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssets_1c57d1d5-10dd-4e51-85a7-5568a86d1a7f" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossLiability_1749c543-6aea-4931-879e-3addeeb5d48a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_dd06b027-32e9-4083-b88a-705a8e6a7404" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_05398e87-9e8a-43f6-b801-24078991d39b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_dd06b027-32e9-4083-b88a-705a8e6a7404" xlink:to="loc_us-gaap_DerivativeAssets_05398e87-9e8a-43f6-b801-24078991d39b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnSecurities_0c4602f3-3f44-44b2-b78a-a01c55754cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCollateralObligationToReturnSecurities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_dd06b027-32e9-4083-b88a-705a8e6a7404" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnSecurities_0c4602f3-3f44-44b2-b78a-a01c55754cbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash_a173f14c-5bee-4f55-9a2b-9ff2c0fe4ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_dd06b027-32e9-4083-b88a-705a8e6a7404" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnCash_a173f14c-5bee-4f55-9a2b-9ff2c0fe4ee0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_613d668b-2b77-4eb2-a720-41244f2ed18f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_4dcb5370-e0eb-4d64-805a-d6aaa4d65141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_613d668b-2b77-4eb2-a720-41244f2ed18f" xlink:to="loc_us-gaap_DerivativeLiabilities_4dcb5370-e0eb-4d64-805a-d6aaa4d65141" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimSecurities_e2c0c5a9-7b67-40ec-9ddc-13930893c76f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCollateralRightToReclaimSecurities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_613d668b-2b77-4eb2-a720-41244f2ed18f" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimSecurities_e2c0c5a9-7b67-40ec-9ddc-13930893c76f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash_a9dafcc2-4e99-49d3-9571-71f5d78d341a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_613d668b-2b77-4eb2-a720-41244f2ed18f" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimCash_a9dafcc2-4e99-49d3-9571-71f5d78d341a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/InventoriesComponentsofInventoriesDetails" xlink:type="simple" xlink:href="jazz-20230331.xsd#InventoriesComponentsofInventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/InventoriesComponentsofInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c48f784d-81f4-499d-a247-ea06f21d8fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_efd25ff9-9ef9-4565-a7ba-a4884365b775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_c48f784d-81f4-499d-a247-ea06f21d8fc6" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_efd25ff9-9ef9-4565-a7ba-a4884365b775" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_570979b9-22c4-47ab-bd1d-6b5cae6b36ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_c48f784d-81f4-499d-a247-ea06f21d8fc6" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_570979b9-22c4-47ab-bd1d-6b5cae6b36ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_8a07eeed-691f-42f6-b6ca-cde16f18b8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_c48f784d-81f4-499d-a247-ea06f21d8fc6" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_8a07eeed-691f-42f6-b6ca-cde16f18b8a9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsGrossCarryingAmountsandNetBookValuesofIntangibleAssetsDetails" xlink:type="simple" xlink:href="jazz-20230331.xsd#GoodwillandIntangibleAssetsGrossCarryingAmountsandNetBookValuesofIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsGrossCarryingAmountsandNetBookValuesofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_03ea7384-6523-47b9-841d-ade5484cc7be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_869a00d2-6d70-4272-8ece-2d312cf9d1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_03ea7384-6523-47b9-841d-ade5484cc7be" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_869a00d2-6d70-4272-8ece-2d312cf9d1cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_88bf2c6b-d1b7-43aa-b8f8-7c9ca4a09be5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_03ea7384-6523-47b9-841d-ade5484cc7be" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_88bf2c6b-d1b7-43aa-b8f8-7c9ca4a09be5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsEstimatedFutureAmortizationCostsDetails" xlink:type="simple" xlink:href="jazz-20230331.xsd#GoodwillandIntangibleAssetsEstimatedFutureAmortizationCostsDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsEstimatedFutureAmortizationCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0dd2b312-2d5e-4165-8bb8-0c726a44b7e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_52e68568-9d0d-4527-9a04-6ffacda9ddc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0dd2b312-2d5e-4165-8bb8-0c726a44b7e7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_52e68568-9d0d-4527-9a04-6ffacda9ddc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_87d4c81c-0745-412d-b2d0-a9b6543051fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0dd2b312-2d5e-4165-8bb8-0c726a44b7e7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_87d4c81c-0745-412d-b2d0-a9b6543051fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_28581ee5-c301-40f4-9180-8242825982e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0dd2b312-2d5e-4165-8bb8-0c726a44b7e7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_28581ee5-c301-40f4-9180-8242825982e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_693d397d-06a1-4089-b3b2-5029670ad744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0dd2b312-2d5e-4165-8bb8-0c726a44b7e7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_693d397d-06a1-4089-b3b2-5029670ad744" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1ebf2137-c8bd-408e-97e5-3e6faa94cd7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0dd2b312-2d5e-4165-8bb8-0c726a44b7e7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1ebf2137-c8bd-408e-97e5-3e6faa94cd7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_2c15e338-dcbe-43f6-8501-d2c8c66b6a11" xlink:href="jazz-20230331.xsd#jazz_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0dd2b312-2d5e-4165-8bb8-0c726a44b7e7" xlink:to="loc_jazz_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_2c15e338-dcbe-43f6-8501-d2c8c66b6a11" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CertainBalanceSheetItemsPropertyandEquipmentDetails" xlink:type="simple" xlink:href="jazz-20230331.xsd#CertainBalanceSheetItemsPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CertainBalanceSheetItemsPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_db033548-7cb1-4292-b599-ef681f5f7d77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_6d4e7733-f482-4904-b96d-78fa431a6a49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_db033548-7cb1-4292-b599-ef681f5f7d77" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_6d4e7733-f482-4904-b96d-78fa431a6a49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_dc03ffa8-ece3-460d-8771-850627d58d33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_db033548-7cb1-4292-b599-ef681f5f7d77" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_dc03ffa8-ece3-460d-8771-850627d58d33" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CertainBalanceSheetItemsOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="jazz-20230331.xsd#CertainBalanceSheetItemsOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CertainBalanceSheetItemsOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_30e031d0-9848-49cb-a043-e42bd1d62875" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_ba4ddf9e-0fed-420a-9092-cd9c7b367497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_30e031d0-9848-49cb-a043-e42bd1d62875" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_ba4ddf9e-0fed-420a-9092-cd9c7b367497" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_DeferredTaxIntercompanyProfitCurrent_e89a7332-6645-45b6-8c79-e0207b031bfb" xlink:href="jazz-20230331.xsd#jazz_DeferredTaxIntercompanyProfitCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_30e031d0-9848-49cb-a043-e42bd1d62875" xlink:to="loc_jazz_DeferredTaxIntercompanyProfitCurrent_e89a7332-6645-45b6-8c79-e0207b031bfb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CertainBalanceSheetItemsAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="jazz-20230331.xsd#CertainBalanceSheetItemsAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CertainBalanceSheetItemsAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_9b0f4dcf-8cdf-4bad-8198-53e41919de3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_07ea4250-f717-4386-bd69-923665a821ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9b0f4dcf-8cdf-4bad-8198-53e41919de3e" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_07ea4250-f717-4386-bd69-923665a821ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_64d64d16-824e-4a41-a81d-aac3a34bb0cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9b0f4dcf-8cdf-4bad-8198-53e41919de3e" xlink:to="loc_us-gaap_InterestPayableCurrent_64d64d16-824e-4a41-a81d-aac3a34bb0cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_616a4258-dead-485d-b0bf-d745b8c76781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9b0f4dcf-8cdf-4bad-8198-53e41919de3e" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_616a4258-dead-485d-b0bf-d745b8c76781" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedInventoryRelatedLiabilitiesCurrent_19b2fa38-3a31-470c-b74b-b9b20671f7b3" xlink:href="jazz-20230331.xsd#jazz_AccruedInventoryRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9b0f4dcf-8cdf-4bad-8198-53e41919de3e" xlink:to="loc_jazz_AccruedInventoryRelatedLiabilitiesCurrent_19b2fa38-3a31-470c-b74b-b9b20671f7b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_d18794da-5d2f-4671-9595-3e388e373f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9b0f4dcf-8cdf-4bad-8198-53e41919de3e" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_d18794da-5d2f-4671-9595-3e388e373f0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_OperatingAndFinanceLeaseLiabilityCurrent_f2dfc267-8e5d-4b5c-8903-48ddab13fbe5" xlink:href="jazz-20230331.xsd#jazz_OperatingAndFinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9b0f4dcf-8cdf-4bad-8198-53e41919de3e" xlink:to="loc_jazz_OperatingAndFinanceLeaseLiabilityCurrent_f2dfc267-8e5d-4b5c-8903-48ddab13fbe5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_2906d400-4fe8-4e42-a0e6-25ac48b3c771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9b0f4dcf-8cdf-4bad-8198-53e41919de3e" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_2906d400-4fe8-4e42-a0e6-25ac48b3c771" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedFacilitiesExpensesCurrent_9fe0bdc6-c003-48df-b5e5-4e213ca441f2" xlink:href="jazz-20230331.xsd#jazz_AccruedFacilitiesExpensesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9b0f4dcf-8cdf-4bad-8198-53e41919de3e" xlink:to="loc_jazz_AccruedFacilitiesExpensesCurrent_9fe0bdc6-c003-48df-b5e5-4e213ca441f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_c93ab5cc-2710-4a21-9a44-d2658972d8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9b0f4dcf-8cdf-4bad-8198-53e41919de3e" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_c93ab5cc-2710-4a21-9a44-d2658972d8d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedClinicalTrialLiabilityCurrent_9f86dc14-d7e0-4bfb-ab54-392a77e3aee7" xlink:href="jazz-20230331.xsd#jazz_AccruedClinicalTrialLiabilityCurrent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9b0f4dcf-8cdf-4bad-8198-53e41919de3e" xlink:to="loc_jazz_AccruedClinicalTrialLiabilityCurrent_9f86dc14-d7e0-4bfb-ab54-392a77e3aee7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedRebatesAndOtherSalesDeductionsCurrent_53882a87-b2ea-4209-b9de-ac01198dd37b" xlink:href="jazz-20230331.xsd#jazz_AccruedRebatesAndOtherSalesDeductionsCurrent"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9b0f4dcf-8cdf-4bad-8198-53e41919de3e" xlink:to="loc_jazz_AccruedRebatesAndOtherSalesDeductionsCurrent_53882a87-b2ea-4209-b9de-ac01198dd37b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SalesReturnReserveCurrent_20b99fbe-1026-424d-8481-68628a81a02f" xlink:href="jazz-20230331.xsd#jazz_SalesReturnReserveCurrent"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9b0f4dcf-8cdf-4bad-8198-53e41919de3e" xlink:to="loc_jazz_SalesReturnReserveCurrent_20b99fbe-1026-424d-8481-68628a81a02f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedCollaborationCostsCurrent_66cea528-603d-4e70-bd28-61b28d1d9ee4" xlink:href="jazz-20230331.xsd#jazz_AccruedCollaborationCostsCurrent"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9b0f4dcf-8cdf-4bad-8198-53e41919de3e" xlink:to="loc_jazz_AccruedCollaborationCostsCurrent_66cea528-603d-4e70-bd28-61b28d1d9ee4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_f430fa78-0c21-4167-a5cd-e8b0f7e7d29f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9b0f4dcf-8cdf-4bad-8198-53e41919de3e" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_f430fa78-0c21-4167-a5cd-e8b0f7e7d29f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedConstructionInProgressCurrent_8839b6cd-b361-40e7-ac77-35ed9b955f3b" xlink:href="jazz-20230331.xsd#jazz_AccruedConstructionInProgressCurrent"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9b0f4dcf-8cdf-4bad-8198-53e41919de3e" xlink:to="loc_jazz_AccruedConstructionInProgressCurrent_8839b6cd-b361-40e7-ac77-35ed9b955f3b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="jazz-20230331.xsd#DebtScheduleofLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DebtScheduleofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_27d98ab2-4fa4-46f2-a1eb-9f43c74e730a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_63f77663-46ff-4715-8bf3-ddd9bd6da801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_27d98ab2-4fa4-46f2-a1eb-9f43c74e730a" xlink:to="loc_us-gaap_LongTermDebtCurrent_63f77663-46ff-4715-8bf3-ddd9bd6da801" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_a97fbe12-f3cc-4877-a5f1-5b19ff858138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_27d98ab2-4fa4-46f2-a1eb-9f43c74e730a" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_a97fbe12-f3cc-4877-a5f1-5b19ff858138" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtScheduleofLongtermDebtDetails_1" xlink:type="simple" xlink:href="jazz-20230331.xsd#DebtScheduleofLongtermDebtDetails_1"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DebtScheduleofLongtermDebtDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f6d77608-c9ce-4ceb-b9a8-8aad900ec3b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a949dc78-1f39-48d8-b37c-898625ae9168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f6d77608-c9ce-4ceb-b9a8-8aad900ec3b3" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_a949dc78-1f39-48d8-b37c-898625ae9168" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_a680f119-d837-4a3f-aee2-d72b7f6dc2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f6d77608-c9ce-4ceb-b9a8-8aad900ec3b3" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_a680f119-d837-4a3f-aee2-d72b7f6dc2d3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtScheduleofMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="jazz-20230331.xsd#DebtScheduleofMaturitiesofLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DebtScheduleofMaturitiesofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_1d2ec732-b265-4918-a243-807aae582031" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_d610a601-247a-4ce8-abb5-0dc26f283fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_1d2ec732-b265-4918-a243-807aae582031" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_d610a601-247a-4ce8-abb5-0dc26f283fc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_daa1ded9-65a2-4239-a810-c83b91154fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_1d2ec732-b265-4918-a243-807aae582031" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_daa1ded9-65a2-4239-a810-c83b91154fc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_134abac8-c77a-401e-b63f-1c55e9442c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_1d2ec732-b265-4918-a243-807aae582031" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_134abac8-c77a-401e-b63f-1c55e9442c3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_94eee297-30da-4a22-b135-ed3f5ceac749" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_1d2ec732-b265-4918-a243-807aae582031" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_94eee297-30da-4a22-b135-ed3f5ceac749" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_LongTermDebtMaturityAfterYearFour_20e610c5-40b0-4e1d-b834-7038193ba640" xlink:href="jazz-20230331.xsd#jazz_LongTermDebtMaturityAfterYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_1d2ec732-b265-4918-a243-807aae582031" xlink:to="loc_jazz_LongTermDebtMaturityAfterYearFour_20e610c5-40b0-4e1d-b834-7038193ba640" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_e26c0ce3-a660-487d-9a2a-b34b9b9baf4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_1d2ec732-b265-4918-a243-807aae582031" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_e26c0ce3-a660-487d-9a2a-b34b9b9baf4a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/NetIncomeperOrdinaryShareBasicandDilutedNetIncomeperCommonShareDetails" xlink:type="simple" xlink:href="jazz-20230331.xsd#NetIncomeperOrdinaryShareBasicandDilutedNetIncomeperCommonShareDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/NetIncomeperOrdinaryShareBasicandDilutedNetIncomeperCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_7f0c9c18-d12c-496d-930b-36ddc35fabfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_67098ede-724e-4292-9b76-58df5ce8cba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_7f0c9c18-d12c-496d-930b-36ddc35fabfa" xlink:to="loc_us-gaap_NetIncomeLoss_67098ede-724e-4292-9b76-58df5ce8cba8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_e4f21622-c46d-4fb5-bae1-7bf55b1165f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_7f0c9c18-d12c-496d-930b-36ddc35fabfa" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_e4f21622-c46d-4fb5-bae1-7bf55b1165f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_653096d6-78d9-4c8a-a392-c54b6cf8e4ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_77a0079e-6bac-47d9-821a-dfdc0bd6d9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_653096d6-78d9-4c8a-a392-c54b6cf8e4ac" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_77a0079e-6bac-47d9-821a-dfdc0bd6d9fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_923de116-218b-41b2-9643-3cfe9c6f4b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_653096d6-78d9-4c8a-a392-c54b6cf8e4ac" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_923de116-218b-41b2-9643-3cfe9c6f4b3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_78917737-6e4e-413f-be4e-f56f6cff5341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_653096d6-78d9-4c8a-a392-c54b6cf8e4ac" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_78917737-6e4e-413f-be4e-f56f6cff5341" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="jazz-20230331.xsd#ShareBasedCompensationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_233011b6-3b89-404c-a4ca-cca607b36904" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_02ac7869-cfc1-4865-bada-025a7aee08b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_233011b6-3b89-404c-a4ca-cca607b36904" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_02ac7869-cfc1-4865-bada-025a7aee08b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_eee1a04f-bd2e-4da2-85ac-236e1d2750b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_233011b6-3b89-404c-a4ca-cca607b36904" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_eee1a04f-bd2e-4da2-85ac-236e1d2750b5" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
